Final version of our paper SSNS candidate gene CLVS1 regulates podocyte oxidative stress— is out https://t.co/J1LytB4349, @JCI_insight. Findings ID potential alt/steroid sparing therapy for NS
Looking forward to tomorrow’s Penn/CHOP Kidney Innovation Center Symposium and Annual Research Day:
“Kidney Genetics and Health Disparities: APOL1, Global Ancestry, and Disease Risk”
📍 Smilow Rubenstein Auditorium, Philadelphia, PA
🗓 Monday, May 11, 2026
An exciting day bringing together leaders in nephrology, genetics, computational biology, and precision medicine to discuss how human genetics and multi-omics are reshaping our understanding of kidney disease and health disparities.
#KidneyResearch #Nephrology #APOL1 #PrecisionMedicine #HealthEquity #PennMedicine #CHOP @PennKidney
🚨 Our new paper just dropped !!! Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes https://t.co/4WCXVKst5S
We’re thrilled to share a breakthrough moment in advancing treatment for #RareKidneyDisease. Our therapy for #FSGS has received FDA approval, the first and only approved medicine for FSGS. #InRareForLife Press release: https://t.co/skl6X2SgZl
Excited to share the link for our new paper in KI. Big step towards predicting response to rx @ initial presentation of Peds nephrotic syndrome @ASPNeph@ISGDtweets@nephcure Huge global collab efforts https://t.co/F9IpDxqh2o
Impt piece of work on precise diagnosis of APOL1 AMKD. Pts with N264K (M1) co-inherited with G2 may have other kid dxs & not AMKD. Huge implications for use of emerging AMKD therapy and interpretation of CT. Congratulations #Simone Sanna-Cherchi and team🎉 https://t.co/wfa9qjY0Io
Enjoy this review focusing on the applicability of KDIGO 2025 guidelines on mx of Peds NS in the US. Highlight, levamisole not approved for use in Humans in the US!! Thanks @goKDIGO for a nice piece. My pleasure working with ChiaShi Wang on this🙏🏽
KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children by Chia-shi Wang and Rasheed Gbadegesin
https://t.co/pKCTItS9m8 (FREE)
We welcomed 25 new members of the Robert J. #LefkowitzSociety at the #Duke#OPSD Physician- Scientist Fall Symposium. The event featured a keynote from Nobel Laurate Dr. Robert Lefkowitz & presentations from Drs. Jenny O’Brien and Michael Forrester. Thanks to everyone who joined!
🎉 Celebrate Duke’s physician-scientist community at OPSD Fall Mini-Symposium on Nov 11, 4–6 PM (MSRBIII Rm 1125)! Featuring Nobel Laureate Dr. Lefkowitz @robertjlefkowi1, research talks & awardee recognition.🥙All Duke trainees/faculty welcome! Read more: https://t.co/3WINiwphCj
Our group is migrating to Bluesky platform. We have already posted a number of cool and new discoveries @gbadegesinlab.bsky.social Please follow our latest updates🙏🏽
Looking forward to having major stakeholders in the room to discuss clinical and research areas of need in rFSGS. Hopefully we can move the needle closer to effective and durable treatments @ASPNeph@ISGDtweets@nephcure 🙏🏽
We are proud of all our Trainees and Early Career Physician Scientists at Duke. We appreciate the great mentor pool that we are blessed with at Duke and the outstanding OPSD staff, present and past. Solid leadership @MaryEKlotman@DukeMedSchool https://t.co/yqpioS78dO